Acura Pharmaceuticals, Inc. Receives Clarification from FDA About Clinical Program; Cash Reserves Update
17 oct. 2005 16h48 HE
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., Oct. 17, 2005 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced receipt from the United States Food and Drug Administration ("FDA") communications clarifying...
Acura Pharmaceuticals, Inc. Receives Communication from FDA
03 oct. 2005 18h07 HE
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., Oct. 3, 2005 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced that the Company has received correspondence from the United States Food and Drug Administration...
Acura Pharmaceuticals, Inc. Secures Bridge Funding
16 sept. 2005 09h30 HE
|
Acura Pharmaceuticals Inc.
PALATINE, Ill, Sept. 16, 2005 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced that the Company has secured $500,000 under a term Loan Agreement (the "Loan") with Essex...
Acura Pharmaceuticals, Inc. Reports Financial Results For Second Quarter 2005 and Commercial Strategy/Cash Reserves Update
14 juil. 2005 16h30 HE
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., July 14, 2005 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced a net loss of $1.4 million or $0.06 per share for the quarter ended June 30, 2005 compared to a...
Acura Pharmaceuticals, Inc. Secures Bridge Funding
22 juin 2005 17h33 HE
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., June 22, 2005 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced that the Company has secured $1 million under a term Loan Agreement (the "Loan") with Essex...
Acura Pharmaceuticals, Inc. Reports Results for First Quarter 2005
02 mai 2005 16h05 HE
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., May 2, 2005 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced net loss of $1,948,000 for the quarter ended March 31, 2005 compared to a net income of $680,000...
Acura Pharmaceuticals, Inc. Announces Commencement of Clinical Trials for Product Candidate No. 2 and Updates Commercial Strategy and Cash Reserves
15 avr. 2005 16h00 HE
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., April 15, 2005 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced the initiation of a clinical trial for the Company's Product Candidate No. 2. Product Candidate...
Acura Pharmaceuticals, Inc. Reports Financial Results, Development Progress and Strategy Update
28 févr. 2005 17h13 HE
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., Feb. 28, 2005 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced a net loss of $2.1 million or $0.09 per share for the three months ending December 31, 2004...
Acura Pharmaceuticals, Inc. Reports Results For Third Quarter 2004, Acceptance of IND Filing by FDA and Commencement of Clinical Trials
12 nov. 2004 17h05 HE
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., Nov. 12, 2004 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced a net loss of $(51,480,000) or $(2.35) per share for the quarter ended September 30, 2004...
Acura Pharmaceuticals, Inc. Announces New Stock Symbol
17 août 2004 11h59 HE
|
Acura Pharmaceuticals Inc.
PALATINE, Ill., Aug. 17, 2004 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced that the Company's common stock will trade under the symbol "ACUR" effective immediately. This...